Cargando…
Time in Therapeutic Range, as a Determinant of All‐Cause Mortality in Patients With Hypertension
BACKGROUND: Accumulating evidence indicates that reducing systolic blood pressure (BP) to <140 mm Hg improves health outcomes; however, an optimal level has not yet been determined. Many population studies or post hoc analyses suggest a target systolic BP between 120 and 140 mm Hg with increased...
Autores principales: | Doumas, Michael, Tsioufis, Costas, Fletcher, Ross, Amdur, Richard, Faselis, Charles, Papademetriou, Vasilios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721788/ https://www.ncbi.nlm.nih.gov/pubmed/29101118 http://dx.doi.org/10.1161/JAHA.117.007131 |
Ejemplares similares
-
Common Secondary Causes of Resistant Hypertension and Rational for Treatment
por: Faselis, Charles, et al.
Publicado: (2011) -
Carotid Baroreceptor Stimulation for the Treatment of Resistant Hypertension
por: Papademetriou, Vasilios, et al.
Publicado: (2011) -
Benefits from Treatment and Control of Patients with Resistant Hypertension
por: Doumas, Michael, et al.
Publicado: (2010) -
Renal Sympathetic Denervation for the Treatment of Difficult-to-Control or Resistant Hypertension
por: Papademetriou, Vasilios, et al.
Publicado: (2011) -
New data, new studies, new hopes for renal denervation in patients with uncontrolled hypertension
por: Papademetriou, Vasilios, et al.
Publicado: (2019)